Download This Paper
Preprints with The Lancet is a collaboration between The Lancet Group of journals and SSRN to facilitate the open sharing of preprints for early engagement, community comment, and collaboration. Preprints available here are not Lancet publications or necessarily under review with a Lancet journal. These preprints are early-stage research papers that have not been peer-reviewed. The usual SSRN checks and a Lancet-specific check for appropriateness and transparency have been applied. The findings should not be used for clinical or public health decision-making or presented without highlighting these facts. For more information, please see the FAQs.
COVID-19 Infection and Efficacy of Vaccination in Patients with Rheumatic Diseases During Omicron Outbreak in South Korea: A Prospective Cohort Study
21 Pages Posted: 19 May 2023
More...Abstract
Background: Epidemiological data on the impact of the Omicron variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on patients with autoimmune inflammatory rheumatic diseases (AIRDs) is lacking. We investigated the incidence of coronavirus disease (COVID-19) caused by the omicron variant and its impact on patients with AIRDs.
Methods: This prospective longitudinal study was performed between January and October, 2022 in South Korea. Patients were classified into AIRD and non-AIRD groups according to their underlying diseases. COVID-19 status, date of confirmed infection, and vaccination status were captured from the patient survey and national database. The COVID-19 incidence during the study period was examined and compared between the two groups. The effect of clinical factors on the infection rate was analyzed in the AIRD group.
Findings: A total of 1814 patients (1535 and 279 in the AIRD and non-AIRD groups, respectively) were analyzed. During the study period, 857 COVID-19 cases were reported in 834 patients (46.0%). The infection rates in the AIRD and non-AIRD groups were comparable. In the AIRD group, older age (≥70 years) and glucocorticoid use were significantly associated with a lower rate of COVID-19 infection. The third booster vaccination significantly lowered the incidence of COVID-19 (adjusted hazard ratio, 0.85[0.73‒0.99]), and the prophylactic effect was more evident in patients aged <70 years (0.81 [0.69‒0.95], P value for interaction 0.046).
Interpretation: The risk of SARS-CoV-2 infection with the Omicron variant did not increase in patients with AIRDs. The third booster vaccination regimen decreased the infection rate in patients aged <70 years.
Funding: This research work was supported by Seoul National University Hospital Research Fund (Grant number: 0420220760).
Declaration of Interest: All the authors have declared no financial, professional, or personal competing interests that might have influenced the performance or presentation of the work described in this manuscript.
Ethical Approval: This study was conducted in accordance with tenets of the Declaration of Helsinki and approved by the Institutional Review Board of Seoul National University Hospital (IRB No. 2207-027-1337). Written informed consent was obtained from all patients.
Keywords: COVID-19, Omicron, SARS-CoV-2, Autoimmune inflammatory disease, Rheumatic disease, South Korea, Vaccine, Epidemiology
Suggested Citation: Suggested Citation